22/05/2025
Danish biotech CelVivo raises DKK 50 million in funding round
The Danish biotech company has raised a total of DKK 50 million in an investment round led by the Danish Export and Investment Fund (EIFO).
CelVivo has developed a 3D cell culture technology that can cultivate cells in an environment resembling the biological conditions of the human body. The technology enables researchers and scientists to conduct more relevant and effective research while achieving faster results.
The DKK 50 million in funds will be used to accelerate global expansion into new markets, especially in the US and Europe.
Mazanti Transactions advised CelVivo in connection with all aspects of the investment.